http://www.zibb.com/all/theme/cq/Clinical+Data,+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Thu, 19 Nov 2009 01:11:14 GMTThu, 19 Nov 2009 01:11:14 GMT608831http://www.zibb.com/all/theme/cq/Clinical+Data,+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.zibb.com/article/5680289/Clinical+Data+Down+Since+SmarTrend+s+Sell+RecommendationSmarTrend, our proprietary pattern recognition system, called a Downtrend for Clinical Data (NASDAQ:CLDA) on October 28, 2009 at $16.58. Since then, Clinical Data has returned 6.5% as of today's recent price of $15.50. Want to profit from these alerts? Go to www.mysmartrend.com now for a FREEhttp://www.zibb.com/article/5680289/Clinical+Data+Down+Since+SmarTrend+s+Sell+RecommendationClinical Data, IncorporatedThu, 19 Nov 2009 01:11:14 GMThttp://www.newratings.com/en/main/company_headline.m?id=1988497NEW YORK, November 10 (newratings.com) - Analysts at Piper Jaffray initiate coverage of Clinical Data (ticker: CLDA) with an "overweight" rating. [more]http://www.newratings.com/en/main/company_headline.m?id=1988497Clinical Data, IncorporatedWed, 11 Nov 2009 14:25:43 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=9456Clinical Data, Inc. (NASDAQ: CLDA) today announced that it intends to offer shares of common stock in an underwritten public offering. Piper Jaffray & Co. is acting as the sole book running manager, with Wedbush PacGrow Life Sciences, Roth Capitahttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=9456Clinical Data, IncorporatedWed, 28 Oct 2009 01:00:00 GMThttp://www.prweb.com/releases/medical/imaging/prweb3074594.htmPR: M2S, Inc. and the Vascular Study Group of New England (VSGNE) have partnered to advance the VSGNE quality improvement registry. Clinical Data Pathways, powered by M2S, is a secure, web-based clinical data management solution that offers physicians, hospitals, medical centers and clinicalhttp://www.prweb.com/releases/medical/imaging/prweb3074594.htmClinical Data, IncorporatedTue, 20 Oct 2009 20:32:38 GMThttp://boston.bizjournals.com/boston/stories/2009/09/14/daily53.html?ana=from_rssTarriff most recently founded Eagle Pharmaceuticals Inc., an in-licensing injectable IV product developer. Before Eagle, he spent nine years at Par Pharmaceuticals Companies Inc.http://boston.bizjournals.com/boston/stories/2009/09/14/daily53.html?ana=from_rssClinical Data, IncorporatedFri, 18 Sep 2009 18:55:14 GMThttp://www.biospace.com/news_story.aspx?StoryID=154902&full=1NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA), today announced that Drew Fromkin, President and Chief Executive Officer, will be presenting a corporate overview at the Eleventh Annual Rodman & Renshaw Healthcare Conference. Clinical Data's presentation will take place at 2:50http://www.biospace.com/news_story.aspx?StoryID=154902&full=1Clinical Data, IncorporatedThu, 03 Sep 2009 12:00:00 GMThttp://www.bizjournals.com/boston/stories/2009/08/10/daily43.html?ana=from_rssA subsidiary of Clinical Data Inc. and CombinatoRx Inc. have signed a licensing agreement valued at up to $257 million in milestone and royalty payments. The collaboration deal calls for Newton, Mass.http://www.bizjournals.com/boston/stories/2009/08/10/daily43.html?ana=from_rssClinical Data, IncorporatedThu, 13 Aug 2009 16:15:16 GMThttp://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/08/13/financial/f083209D39.DTL&feed=rss.businessClinical Data Inc. said Thursday it licensed a potential cancer treatment to CombinatoRx in a deal worth as much as $252 million, plus royalties on sales. The drug candidate, designated ATL313, is in preclinical testing. It is seen as a possible treatment for...<br clear="both"http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2009/08/13/financial/f083209D39.DTL&feed=rss.businessClinical Data, IncorporatedThu, 13 Aug 2009 15:32:26 GMThttp://www.newsvine.com/_news/2009/08/13/3149292-clinical-data-licenses-cancer-drug-for-252mClinical Data Inc. said Thursday it licensed a potential cancer treatment to CombinatoRx in a deal worth as much as $252 million, plus royalties on sales.http://www.newsvine.com/_news/2009/08/13/3149292-clinical-data-licenses-cancer-drug-for-252mClinical Data, IncorporatedThu, 13 Aug 2009 15:32:09 GMThttp://www.genengnews.com/news/bnitem.aspx?name=60392772Clinical Data licensed its preclinical candidate for B-cell cancers to CombinatoRx in a deal worth up to $252 million. CombinatoRx will initially develop this adenosine A2A The $25http://www.genengnews.com/news/bnitem.aspx?name=60392772Clinical Data, IncorporatedThu, 13 Aug 2009 00:00:00 GMThttp://www.pharmaasia.com/article-7842-gcdmpdatamanagementstandardstoreceivejapanesetranslation-asia.htmlThe Society for Clinical Data Management’s (SCDM) Good Clinical Data Management Practices (GCDMP) will be translated to Japanese and be published by the Center for Pharmaceutical Publication of Tokyohttp://www.pharmaasia.com/article-7842-gcdmpdatamanagementstandardstoreceivejapanesetranslation-asia.htmlClinical Data, IncorporatedFri, 17 Jul 2009 00:00:00 GMThttp://www.prlog.org/10277294-scdms-data-management-best-practices-to-receive-japanese-translation.htmlSCDM's data management best practices to receive Japanese translation. Good Clinical Data Management Practices resource will serve as international standardhttp://www.prlog.org/10277294-scdms-data-management-best-practices-to-receive-japanese-translation.htmlClinical Data, IncorporatedWed, 08 Jul 2009 16:17:30 GMThttp://finance.yahoo.com/news/Avalon-Pharmaceuticals-bw-15060433.html?.v=1GERMANTOWN, Md.--(BUSINESS WIRE)--Avalon Pharmaceuticals, Inc. (Nasdaq:AVRX - News), today announced that it has scheduled a special meeting ofhttp://finance.yahoo.com/news/Avalon-Pharmaceuticals-bw-15060433.html?.v=1Clinical Data, IncorporatedTue, 28 Apr 2009 20:49:00 GMThttp://www.pharmaceutical-business-review.com/article_news.asp?guid=704A287A-504A-4C46-B20B-B50A69671B78Clinical Data, a biotechnology company, has announced that its Cogenics division, a provider of outsourced genomics services, has become the exclusive global provider of genotyping solutions for Astellas Pharma, a manufacturer of pharmaceuticals and related products.http://www.pharmaceutical-business-review.com/article_news.asp?guid=704A287A-504A-4C46-B20B-B50A69671B78Clinical Data, IncorporatedTue, 25 Nov 2008 13:56:00 GMThttp://networks.silicon.com/mobile/0,39024665,39344716,00.htmQualcomm switches attention to LTE. The ongoing fight to be a next-generation wireless contender has lost one of its combatants, ashttp://networks.silicon.com/mobile/0,39024665,39344716,00.htmClinical Data, IncorporatedMon, 17 Nov 2008 14:59:01 GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=1266lm20o/*http://boston.bizjournals.com/boston/stories/2008/10/27/daily12.html?ana=yfcpcNewton, Mass.-based Clinical Data (Nasdaq: CLDA) said the acquisition of Avalon Pharmaceuticals (Nasdaq: AVRX) in Germantown, Md., will help expand its cancer business with technology to help identify both new diagnostics and treatments.http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=1266lm20o/*http://boston.bizjournals.com/boston/stories/2008/10/27/daily12.html?ana=yfcpcClinical Data, IncorporatedTue, 28 Oct 2008 15:25:10 GMThttp://www.xconomy.com/boston/2008/10/28/clinical-data-buys-avalon-pharma-for-10m/Clinical Data (NASDAQ:[[ticker:CLDA]]), a Newton, MA-based biotech firm, announced today that it has acquired Avalon Pharmaceuticals (NASDAQ:[[ticker:AVRX]]),http://www.xconomy.com/boston/2008/10/28/clinical-data-buys-avalon-pharma-for-10m/Clinical Data, IncorporatedTue, 28 Oct 2008 14:06:42 GMThttp://biz.yahoo.com/bw/081028/20081028005894.html?.v=1Clinical Data, Inc. to Acquire Avalon Pharmaceuticals. - NEWTON, Mass. & GERMANTOWN, Md.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA - News) and Avalon Pharmaceuticals, Inc. (NASDAQ: AVRX - News) today announced that they have entered into a definitive merger agreement for Clinical Data tohttp://biz.yahoo.com/bw/081028/20081028005894.html?.v=1Clinical Data, IncorporatedTue, 28 Oct 2008 12:26:00 GMThttp://www.canadianbusiness.com/markets/headline_news/article.jsp?content=D92G6UCG0NEWTON, Mass. (AP) - Biotechnology company Clinical Data Inc. reported a wider loss of $14.8 million for its first fiscal quarter, as it saw steep increases in research and sales and marketing costs. The loss, which equaled 70 cents per share, increased from a loss of $5.http://www.canadianbusiness.com/markets/headline_news/article.jsp?content=D92G6UCG0Clinical Data, IncorporatedMon, 11 Aug 2008 17:52:00 GMThttp://www.istockanalyst.com/article/viewarticle+articleid_2469402.htmlAstraZeneca PLC's (AZN) key drugs such as Crestor (cholesterol), Seroquel (schizophrenia) and Symbicort (asthma) will continue to be the driving force of growth until the company can commercialize its pipeline. Company-wide revenue growth will slow consid<ahttp://www.istockanalyst.com/article/viewarticle+articleid_2469402.htmlClinical Data, IncorporatedMon, 04 Aug 2008 12:55:00 GMThttp://www.businessweek.com/investor/content/aug2008/pi2008081_022911.htm?campaign_id=yhooActivist investor Randal Kirk, who knows from companies that have attracted the eye of Big Pharma, finds the company's new antidepressant, Vilazodone, a reason to feel better.http://www.businessweek.com/investor/content/aug2008/pi2008081_022911.htm?campaign_id=yhooClinical Data, IncorporatedMon, 04 Aug 2008 12:08:48 GMThttp://www.fiercebiotech.com/press-releases/roche-makes-offer-acquire-all-outstanding-shares-genentech-us-89-00-share-cash-0Roche makes offer to acquire all outstanding shares of Genentech for US$89.00 per share in cash Combination to enhance innovation by allowing for diversity of research approaches while also... Read more...http://www.fiercebiotech.com/press-releases/roche-makes-offer-acquire-all-outstanding-shares-genentech-us-89-00-share-cash-0Clinical Data, IncorporatedMon, 21 Jul 2008 13:29:56 GMThttp://seekingalpha.com/article/84822-immunogen-s-wild-swings-due-to-lack-of-information-at-asco?source=feedOhad Hammer submits:Many terms can be used to describe Immunogens (IMGN) recent stock behavior, but it seems the word schizophrenic is the most suitable one. Immunogen gained almost 50% in the three weeks prior to the ASCO annual meeting, just to give it allhttp://seekingalpha.com/article/84822-immunogen-s-wild-swings-due-to-lack-of-information-at-asco?source=feedClinical Data, IncorporatedMon, 14 Jul 2008 09:41:51 GMThttp://www.news-medical.net/?id=39544Clinical Data, Inc. has announced that the European Patent Office has granted Patent No. 1232260 to Bernried, Germany-based Epidauros Biotechnologie AG, a wholly-owned subsidiary of Clinical Data, relating to the use of a genetic variant, or biomarker, of the gene MDR1 (also known as ABCB1), whichhttp://www.news-medical.net/?id=39544Clinical Data, IncorporatedThu, 26 Jun 2008 11:38:00 GMThttp://www.smartbrief.com/news/NRA/industryBW-detail.jsp?id=A2C059F1-1104-4FA6-89E3-2281FD6056C6&sb_code=RSS&i=FoodserviceSAS(R) for Clinical Data Integration Helps Reduce Time-to-Market for New Drugshttp://www.smartbrief.com/news/NRA/industryBW-detail.jsp?id=A2C059F1-1104-4FA6-89E3-2281FD6056C6&sb_code=RSS&i=FoodserviceClinical Data, IncorporatedMon, 23 Jun 2008 12:31:34 GMT